Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

1893161 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
RECKITT : Receives a Buy rating from UBS
ZD
NOKIA : UBS sticks Neutral
ZD
AIR LIQUIDE(L) : UBS reiterates its Buy rating
ZD
BASF SE : UBS keeps its Buy rating
ZD
AST SpaceMobile CEO Publishes Letter to Partners, Shareholders, and Future Space-Based Cellular Broadband Network Users
BU
MOLLER-MAERSK : Bernstein gives a Sell rating
ZD
Customers Bancorp Announces Common Stock Repurchase Plan
BU
BlackRock Adds Max Buffer ETF to Active ETF Platform
BU
BOEING CO : RBC reaffirms its Buy rating
ZD
AKZO NOBEL NV : UBS reiterates its Buy rating
ZD
NASDAQ Grants Eightco’s Request for Continued Listing on The Nasdaq Capital Market
AQ
Alzinova’s rights issue is registered – conversion of BTA into shares
AQ
Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors
AQ
AIR FRANCE-KLM : Bernstein reiterates its Buy rating
ZD
AB INBEV : Bernstein reiterates its Buy rating
ZD
Trelleborg : Pump and roll
PU
Hain Celestial Powers Towards a Healthier Planet by Generating Electricity from Fruit
PR
Merck and Orion Announce Mutual Exercise of Option Providing Merck Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer
BU
Inside information: Orion upgrades full-year outlook for 2024
GL
Inside information: Orion and MSD Announce Mutual Exercise of Option Providing MSD Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer
GL
Misuse Of The Complaints Mechanism On An E-commerce Platform
AQ
Masimo Nominee Christopher Chavez Would Bring Fierce Independence, Exemplary Medtech CEO Experience to Masimo Board
BU
Nicholas Cumins Takes Charge as CEO of Bentley Systems, Ushering in a New Era
BU
INVESTIGATION NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Target Hospitality Corp. (NASDAQ: TH) and Encourages Investors with Losses to Contact the Firm
BU
POWERSCHOOL FAIRNESS INVESTIGATION: Kaskela Law LLC Announces Shareholder Investigation of PowerSchool Holdings, Inc. (NYSE: PWSC) and Encourages Investors to Contact the Firm
BU
SARTORIUS VORZUEGE : Deutsche Bank gives a Neutral rating
ZD
RENAULT SA : JP Morgan reiterates its Buy rating
ZD
Perfect Corp. Partners with NAO-ART to Power First-of-its-Kind Generative AI Wig Virtual Try-On Experience in Japan
BU
Neurocrine Biosciences Gets FDA Priority Review for Crinecerfont
DJ
NextDecade Subsidiary Rio Grande LNG Announces Issuance of $1.115 Billion Senior Secured Notes Due 2047
BU
DiaMedica Therapeutics Announces Closing of $11.8 Million Private Placement
BU
SCHNEIDER ELECTRIC : UBS reiterates its Buy rating
ZD
Kashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab)
BU
DAIMLER TRUCK : Deutsche Bank maintains a Buy rating
ZD
Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy
GL
NiSource Demonstrates Commitment to Furthering a More Sustainable and Inclusive Future through 2024 ESG Report
BU
BOEING CO : Jefferies keeps its Buy rating
ZD
Kraig Biocraft Laboratories Expands Facilities to Support Spider Silk Production Growth
AQ
Microvast Celebrates Four Years of Supplying High-Performance Battery Systems to eVersum
BU
CBIH Submits Groundbreaking Cannabis Patents for Breast and Pancreatic Cancer Treatments
NE
Amneal Expands Biosimilars Portfolio to Eight Products with Addition of Omalizumab Biosimilar
BU
Jefferies cuts target for SMA Solar to 30 euros - 'Hold'
DP
Business Update
GL
Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations
GL
Stellantis to Announce First Half 2024 Results on July 25
GL
Arteris Joins Russell 2000® Index
AQ
Humacyte Acellular Tissue Engineered Vessel (ATEV™) Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for Patients with Advanced Peripheral Artery Disease (PAD)
AQ
Korro Joins the Russell 2000®, Russell 3000®, and Russell Microcap® Indexes
AQ
Biora Therapeutics Announces Positive Clinical Trial Results for BT-600
AQ
CBIH advances Cancer Care with Novel Cannabis Patents for Breast and Pancreatic Cancers
AQ
No results for this search
  1. Stock Market
  2. Advanced search
  3. 가상계좌임대 @MOONPAY_CALL 코인가상계좌 농협은행 신협은행가상 농협은행가상계좌 target=_blank
  4. News